Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Knight Therapeutics Inc T.GUD

Alternate Symbol(s):  KHTRF

Knight Therapeutics Inc. is a specialty pharmaceutical company. The Company’s principal business activity is developing, acquiring, in-licensing, out-licensing, manufacturing, marketing and distributing pharmaceutical products in Canada, Latin America and select international markets. It finances other life sciences companies and secures product distribution rights for Canada and select international markets. The Company invests in life sciences venture capital funds whereby the Company may receive preferential access to healthcare products for Canada and select international markets. It develops pharmaceutical products, including those to treat neglected tropical and rare pediatric diseases. The portfolio consists of pharmaceutical products with molecules and includes both in-licensed products such as Lenvima, Cresemba, Halaven, Trelstar, Akynzeo, Ambisome, Minjuvi, Imvexxy as well as products owned by Knight such as Exelon and Impavido.


TSX:GUD - Post by User

Post by Chianchinon Jul 11, 2023 7:16pm
140 Views
Post# 35536490

let's do some math so we can help mugsy

let's do some math so we can help mugsy Mugsy claims to have accumulate GUD shares  for the past 10 years or so. Let's be kind and assume that mugsy GUD avarage cost is $7. Ha...let's say that the avarage inflation rate is 3% over 10 Years. Conpounding 3% loss over 10 Years should be more or less 45% thus Mugsy's GUD real cost is more or less  $7 plus $3 ..say $10. This calculation is based on a discounted inflation rate OPPORTUNITY COST, 
Than there is the opportunity loss based on the index of the market which over 10 Years has returned close to 50% so MUGSY $7 buckes Should be close to $11. 
Mugsy is at $4.80 and gets all hyper when GUD rises to $4.90
Either way you look at it mugsy is losing fortunes and shirts but mugsy would like to give investors advices because he knows. BTW Mugsy other big investment is in ATE. Here mugsy has lost it all 
POOR MUGSY 
<< Previous
Bullboard Posts
Next >>